StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) operating KPIs

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)

Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%

Johnson & Johnson over-the-Counter (OTC) Medicines (TYLENOL, MOTRIN, ZYRTEC) — Worldwide operational (constant-currency) growth YoY (%) (%)

Form 8-K EX-99.2 Segment Sales Schedule

QuarterlyAnnual
Latest, FY2022
11.2%
Period ended Jan 1, 2023
Change on a year earlier
+5.0 pts
6.2% in FY2021
History
6 years
Since FY2017
Sources
6
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOver-the-Counter (OTC) Medicines (TYLENOL, MOTRIN, ZYRTEC) — Worldwide operational (constant-currency) growth YoY (%) (%)Year on yearSource
FY2022Jan 1, 202311.2%+5.0 ptsForm 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗
FY2021Jan 2, 20226.2%-3.2 ptsForm 8-K (a2021q4exhibit991.htm, filed 2022-01-25) ↗
FY2020Jan 3, 20219.4%+4.5 ptsForm 8-K (a2020q4exhibit991.htm, filed 2021-01-26) ↗
FY2019Dec 29, 20194.9%+0.5 ptsForm 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗
FY2018Dec 30, 20184.4%+1.8 ptsForm 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗
FY2017Dec 31, 20172.6%–Form 8-K (a8k2017q4exhibit9915.htm, filed 2018-01-23) ↗

Breakdown

What makes up over-the-counter (otc) medicines (tylenol, motrin, zyrtec) — worldwide operational (constant-currency) growth yoy (%)

Cite this data

StockData. (2026). Johnson & Johnson Over-the-Counter (OTC) Medicines (TYLENOL, MOTRIN, ZYRTEC) — Worldwide operational (constant-currency) growth YoY (%) (%), annual FY2017–FY2022 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/ch_otc_ops_yoy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.